Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PrenaTest® is Now Applicable for Multiple Pregnancies

Published: Tuesday, February 11, 2014
Last Updated: Tuesday, February 11, 2014
Bookmark and Share
To be generally applied after IVF, egg donation and other infertility treatments.

As Europe’s first non-invasive molecular diagnostic blood test for the determination of fetal chromosomal aneuploidies from maternal blood, PrenaTest® has now successfully been validated for use in multiple pregnancies.

It is the only blood test that can be used without any restriction following all methods of fertility treatment, such as IVF or egg donation, after the 9th week of gestation.

To date, several thousand PrenaTest® analysis have been successfully performed in singleton pregnancies.

The number of multiple pregnancies has steadily increased in Germany over the last years due to an increased use of fertility treatments especially with women of higher age.

For these, PrenaTest® is a valuable and risk-free improvement for the determination of fetal chromosomal aneuploidies given the significantly increased risk for miscarriage following an invasive diagnostic procedure like amniocentesis, compared to such risk in case of singleton pregnancies.

In addition, conventional non-invasive examinations such as first trimester screening show a two to three fold increase with respect to the false positive rate.

"We are happy to report that we correctly classified all trisomy cases with the PrenaTest® in a validation study which included 62 twin and triplet pregnancies,” said Dr. Michael Lutz , CEO of LifeCodexx AG. "With the successful validation of the PrenaTest® for multiple pregnancies, we have set high standards again in this innovative field of non-invasive prenatal diagnosis."

In addition, the innovative PrenaTest® express is now available in other European countries, too. This express version of the PrenaTest® provides the test results in one week and thus shortens the stressful waiting period for pregnant women to a minimum. In Germany about every fourth patient opts for the express version.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novel qPCR-based PrenaTest® Successfully Validated in Clinical Study
LifeCodexx AG’s cost-efficient NIPT assay to provide results on fetal trisomy 21 in 48 hours.
Thursday, December 03, 2015
PrenaTest® is Now Reimbursed by Swiss Statutory Health Insurance Programs
The first reimbursement worldwide of non-invasive prenatal tests by a national healthcare system.
Wednesday, July 08, 2015
Improved PrenaTest® Provides Early Knowledge for High Risk Pregnancies
PrenaTest® can now be performed after the ninth week of pregnancy.
Wednesday, July 10, 2013
Scientific News
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Diagnosing Bacterial Infections in Blood Samples
Researchers have diagnosed a bacterial infection from a blood sample in infants.
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Misdiagnosis in HCM Tests
Genetic tests for potentially fatal heart anomaly can misdiagnose condition in black Americans.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Examining New Hypotheses for Undiagnosed Patients
UnDx Consortium gathers in San Diego to create new paths to identifying currently undiagnosed illnesses.
Automating Genetic Analysis
Researchers are looking to have computers help perform genetic analysis when scientists study a patient's genome to diagnose a disease.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!